Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: DIASORIN MOLECULAR, LLC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2022-09-30 to 2024-12-31
Current total value of award: $30954000
Description: POINT-OF-CARE (POC) MOLECULAR DIAGNOSTICS PLATFORM FOR A DISTRIBUTED PHARMACY NETWORK IN THIS EFFORT, LUMINEX CORPORATION, A DIASORIN COMPANY, AIMS TO UNLOCK THIS UNREALIZED POTENTIAL FOR DISEASE DETECTION AND CONTROL BY DEVELOPING, VERIFYING AND C